Alternative Medications for Gonorrhea When Ceftriaxone Is Unavailable
If ceftriaxone is unavailable, use cefixime 400 mg orally plus azithromycin 1 g orally as a single dose, with mandatory test-of-cure at 1 week. 1
First-Line Alternative: Oral Cefixime
Cefixime 400 mg orally plus azithromycin 1 g orally (both single dose) is the CDC-recommended alternative when ceftriaxone cannot be obtained. 1, 2
Efficacy by Anatomic Site
- Cefixime achieves 97.4% cure for urogenital infections and 97% cure for rectal infections, but only 78.9–89% cure for pharyngeal infections—significantly lower than ceftriaxone's 99% rate. 1, 3
- The reduced pharyngeal efficacy is critical because pharyngeal gonorrhea is a key site for antimicrobial resistance emergence and can persist asymptomatically for up to 16 weeks. 4
- Cefixime provides lower and less sustained bactericidal levels than ceftriaxone, explaining its reduced overall effectiveness. 1
Mandatory Follow-Up
- Test-of-cure is required at 1 week (7 days post-treatment) for all cefixime-treated patients due to rising minimum inhibitory concentrations and declining effectiveness. 1
- Use culture (preferred, allows susceptibility testing) or nucleic acid amplification test if culture unavailable; if NAAT positive, confirm with culture and perform antimicrobial susceptibility testing. 1
Severe Cephalosporin Allergy Options
Azithromycin Monotherapy
For patients with documented severe cephalosporin allergy, azithromycin 2 g orally as a single dose is an option, but has only 93% efficacy and high gastrointestinal side effects. 1, 5
- Mandatory test-of-cure at 1 week is required. 5
- This regimen should never be used as routine therapy due to lower efficacy and risk of rapid resistance emergence. 1
- Azithromycin resistance ranges from 4–7% in North America but can reach 66% in East Asian regions. 1
Gentamicin Plus Azithromycin
Gentamicin 240 mg IM plus azithromycin 2 g orally (single dose) achieved 100% microbiological cure in clinical trials but has poor pharyngeal efficacy. 1, 6
- A large randomized controlled trial found gentamicin cleared only 80% of pharyngeal infections versus 96% for ceftriaxone, and 90% of rectal infections versus 98% for ceftriaxone. 7
- One study was stopped early because only 2 of 10 individuals with pharyngeal gonorrhea treated with gentamicin were cured (20% efficacy). 4, 1
- Gentamicin causes significantly more injection site pain than ceftriaxone. 7
- This regimen should only be used when azithromycin susceptibility is confirmed, particularly in regions with high azithromycin resistance. 1
Spectinomycin
Spectinomycin 2 g IM achieves 98.2% cure for urogenital and anorectal infections but only 52% cure for pharyngeal infections. 4, 1, 2
- Spectinomycin should be avoided when pharyngeal exposure is possible or suspected. 1
- For pregnant patients with severe cephalosporin allergy, spectinomycin 2 g IM plus azithromycin 1 g orally is acceptable, though pharyngeal efficacy remains poor. 1
Other Alternative Cephalosporins (When Ceftriaxone Unavailable)
The following injectable cephalosporins are effective but offer no advantage over ceftriaxone: 4, 2
- Ceftizoxime 500 mg IM (single dose)
- Cefoxitin 2 g IM with probenecid 1 g orally (single dose)
- Cefotaxime 500 mg IM (single dose)
Contraindicated Medications
Fluoroquinolones
Fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin) are absolutely contraindicated for gonorrhea treatment due to widespread resistance, despite historical cure rates exceeding 99%. 1, 8
- Quinolones should never be used, even if susceptibility testing suggests activity, because resistance patterns have rendered them universally ineffective. 1
- Quinolones are also contraindicated in individuals ≤17 years of age and during pregnancy. 1
Azithromycin Monotherapy
Azithromycin 1 g alone should never be used for gonorrhea treatment—it achieves only 93% efficacy and risks rapid resistance emergence. 1
Treatment Failure Management
If treatment failure is suspected: 1, 5
- Obtain specimens from all potentially infected sites for culture with antimicrobial susceptibility testing immediately
- Report the case to local public health officials within 24 hours
- Consult an infectious disease specialist
- Recommended salvage regimens include:
Special Populations
Pregnancy
- Pregnant patients should receive ceftriaxone 500 mg IM plus azithromycin 1 g orally. 1
- Never use quinolones, tetracyclines, or doxycycline in pregnancy due to fetal safety concerns. 1, 5
- If severe cephalosporin allergy exists, use spectinomycin 2 g IM plus azithromycin 1 g orally. 1
Men Who Have Sex with Men
- Ceftriaxone is the only recommended treatment for MSM due to higher prevalence of resistant strains; quinolones must never be used in this population. 1
Critical Partner Management
- All sexual partners from the preceding 60 days must be evaluated and treated with the same dual therapy regimen, regardless of symptoms or test results. 1, 5
- Partners should receive ceftriaxone 500 mg IM plus azithromycin 1 g orally, or cefixime 400 mg plus azithromycin 1 g orally if ceftriaxone unavailable. 1
- Patients must abstain from sexual intercourse until therapy is completed and both patient and all partners are asymptomatic. 1
Common Pitfalls to Avoid
- Never assume oral cephalosporins are equivalent to ceftriaxone—they have inferior efficacy, especially for pharyngeal infections. 1
- Never omit test-of-cure when using alternative regimens—it is mandatory for cefixime and azithromycin monotherapy. 1
- Never use gentamicin or spectinomycin for suspected pharyngeal gonorrhea—both have unacceptably low cure rates at this site. 4, 1
- Never use cefixime as monotherapy without azithromycin—this violates CDC dual therapy recommendations. 1